Jane Street’s Traws Pharma TRAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.9K Buy
+21,241
New +$39.9K ﹤0.01% 11049
2024
Q3
Sell
-1,002
Closed -$11.2K 10561
2024
Q2
$11.2K Buy
+1,002
New +$16.1K ﹤0.01% 9101
2023
Q2
Sell
-412
Closed -$7.53K 9719
2023
Q1
$7.53K Sell
412
-194
-32% -$4.2K ﹤0.01% 8768
2022
Q4
$9.79K Buy
+606
New +$11.4K ﹤0.01% 8767
2022
Q3
Sell
-599
Closed -$20K 10626
2022
Q2
$20K Buy
+599
New +$20.2K ﹤0.01% 9163
2020
Q4
Sell
-305
Closed -$32K 8227
2020
Q3
$32K Buy
305
+172
+129% +$42.5K ﹤0.01% 6982
2020
Q2
$28K Buy
+133
New +$20.3K ﹤0.01% 6938

Other funds holding TRAW

Jane Street's TRAW Position: Q1 2026 in Review

Jane Street opened a new position in Traws Pharma (TRAW) in Q1 2026: 21,241 shares worth $38.9K. The stake represents ﹤0.01% of the portfolio and ranks #11049 among its holdings. This is a return to the name: Jane Street previously reported a position in TRAW as recently as Q2 2024.

Jane Street first reported a position in TRAW in Q2 2020 and has held it in 7 quarters since. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Jane Street held 21,241 shares of Traws Pharma worth $38.9K as of Q1 2026.
  • Traws Pharma was a new Jane Street position in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11049 holding.
  • Jane Street first reported a position in Traws Pharma in Q2 2020 and has held it in 7 quarters since.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.